Brain Tumour Foundation of Canada is a national, not-for-profit organization dedicated to reaching every Canadian affected by a brain tumour through support, education, information and research.
Brain Tumour Foundation of Canada is seeking outstanding researchers conducting quality glioblastoma research. All such proposals will be given consideration. We are interested in receiving innovative research proposals which incorporate novel or original concepts that have the potential to make a difference in the lives of patients and projects that involve collaboration.
TYPES OF RESEARCH FUNDED
Applications will be considered for Basic, Clinical, Translational and Population Studies Research relevant to neuro-oncology.
Basic Research: In this context, ‘Basic’ research involves the development of new concepts (eg. signaling pathways using an in vitro model). Basic science research is meant to increase our scientific knowledge base, with the intent of bettering our understanding of the cause and progression of brain tumours.
Clinical Research: Research in which people, or data or samples of tissue from people, are studied to understand health and disease. Clinical research helps find new and better ways to detect, diagnose, treat, and prevent disease and improve quality of life. Types of clinical research include clinical trials, which test new treatments for a disease, and natural history studies, which collect health information to understand how a disease develops and progresses over time or how the disease impacts quality of life.
Translational Research: In this context, ‘Translational’ is defined as pre-clinical research evaluating the therapeutic potential of recent discoveries in the basic mechanisms of either brain tumour pathogenesis or experimental therapeutics. Human studies are excluded.
Population Study: A study of a group of individuals taken from the general population who share a common characteristic, such as age, sex, or health condition. Groups may be studied to identify associations between various exposures and disease outcomes (for example: environmental exposures and the occurrence of a specific tumour type; treatments and variation in tumour response/patient survival).
Researchers who receive an elevation grant from Brain Tumour Foundation of Canada will be asked to submit a report after the first 9 months to allow for consideration of year two funding after the first year. Notification of publications resulting from the project should be forwarded to Susan Ruypers. This information will be shared with our donors, supporters, and other individuals through our publications and at events organized by Brain Tumour Foundation of Canada, for our community. A financial report is required at the end of each year funding is provided, in the format used at your institution.
SELECTION CRITERIA
1. Qualifications of applicant and the study team.
2. Quality of the research proposal.
3. Resources at the proposed laboratory or institution to support the conduct of the project.
4. Significance (contribution project will have on lives of BT patients/caregivers/HCPs)
5. Studies that include early career investigators will be given special consideration.
6. Collaborative participants/expertise.
Sponsor Institute/Organizations: Brain tumor foundation of canada
Sponsor Type:
Address: 205 Horton St E, Suite 203 London, ON N6B 1K7
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Apr 18, 2025
Apr 18, 2025
$50,000
Affiliation: Brain tumor foundation of canada
Address: 205 Horton St E, Suite 203 London, ON N6B 1K7
Website URL: https://www.braintumour.ca/wp-content/uploads/2025/01/2025-Glioblastoma-Elevation-Research-Grant-Guidelines-FINAL.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.